regadenoson

NDC 36000-364 · Baxter Healthcare Corporation

Generic nameregadenoson

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)REGADENOSON

Strength.08 mg/mL

Pharmacologic classAdenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]

Marketing categoryANDA

Packages

36000-364-01 — 1 SYRINGE, PLASTIC in 1 CARTON (36000-364-01) / 5 mL in 1 SYRINGE, PLASTIC

J2785 — Injection, regadenoson, 0.1 mg Medicare Part B payment limit (ASP + 6%): $2.79

FDA lists these products with the same active ingredient.

0469-6501 — regadenoson, 10135-803 — Regadenoson, 16729-477 — REGADENOSON, 51662-1448 — LEXISCAN(R) (REGADENOSON), 55150-443 — regadenoson, 60505-6116 — regadenoson, 60505-6288 — regadenoson, 68083-175 — Regadenoson, 71288-201 — Regadenoson, 83032-001 — Regadenoson, 85742-012 — Regadenoson

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.